Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis

Go back to Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
(NASDAQ: NXTS) Delayed: 0.70 -0.06 (7.89%)
Previous Close $0.76    52 Week High $ 
Open $0.71    52 Week Low $ 
Day High $0.75    P/E N/A 
Day Low $0.64    EPS $ 
Volume 119,281